UBE(Unilateral Biportal Endoscopy) 시장 예측(-2030년) : 제품별, 용도별, 최종사용자별, 지역별 세계 분석

According to Stratistics MRC, the Global Unilateral Biportal Endoscopy Market is accounted for $977.16 million in 2024 and is expected to reach $1550.62 million by 2030 growing at a CAGR of 8.0% during the forecast period. Spinal surgery is the main application for the sophisticated minimally invasive surgical technique known as unilateral biportal endoscopy (UBE). A high-definition camera and surgical tools are inserted through two tiny incisions on the same side of the body in order to view and treat spinal disorders. Compared to open surgery, UBE has a number of benefits, including less tissue damage, quicker recovery, and less muscle dissection. With the least amount of disturbance to the surrounding structures, the technique enables precise, direct access to the spine, it has grown in popularity for procedures like spinal fusion, discectomy, and decompression because it offers patients a less invasive and more efficient option than traditional techniques.

According to the National Institutes of Health (NIH), minimally invasive spine surgery, including techniques like unilateral biportal endoscopy, has been shown to reduce recovery times by up to 50%, minimize postoperative pain by 30-40%, and decrease hospital stays by 20-30% compared to traditional open spine surgery.

Market Dynamics:

Driver:

Growing Need for Outpatient Treatments

Outpatient surgeries are becoming more and more popular as a result of healthcare systems around the world focusing more on cutting costs. This model is ideal for UBE since its minimally invasive technique results in shorter hospital stays and faster recovery times, enabling patients to resume their regular activities more quickly. Additionally, an increasing number of insurers are supporting this trend by covering UBE procedures because they understand how efficient and cost-effective they are. It is anticipated that UBE's role in outpatient surgery will grow as healthcare providers seek to reduce operating expenses and the strain on inpatient facilities.

Restraint:

Expensive initial equipment costs

The high expense of the required technology and equipment is one of the main obstacles to the broad use of UBE. The cost of purchasing and maintaining the endoscopic tools, cameras, and sophisticated imaging systems needed for UBE procedures is high. Furthermore, these systems require large investments from hospitals and clinics, which can be prohibitive, particularly in areas with low and middle incomes. Despite the possible long-term cost savings associated with quicker recovery times and shorter hospital stays, these high upfront costs may prevent some healthcare providers from implementing UBE.

Opportunity:

Technological developments and robotics integration

The combination of UBE and robotic-assisted technologies offers a significant chance to improve surgical control and precision. Combining robotic systems with UBE could further enhance patient outcomes by giving surgeons more accuracy during minimally invasive procedures. UBE may also be useful in enhancing surgical navigation and results through the application of AI and machine learning. Moreover, UBE may become the method of choice for complex surgeries as a result of these technological advancements, which would propel its expansion in specialty medical facilities.

Threat:

Competition from conventional surgical techniques

Traditional open surgeries and other minimally invasive procedures are still frequently employed despite the increasing use of UBE. Many surgeons continue to feel more at ease using these tried-and-true techniques because they have been proven safe and effective by decades of clinical data. Furthermore, healthcare providers and hospitals are reluctant to invest in newer technologies like UBE because they frequently prioritize tried-and-true, affordable treatments. The market for UBE may face serious obstacles as a result of this ingrained preference for conventional techniques, which could impede its adoption in particular areas or specialties.

Covid-19 Impact:

The market for unilateral biportal endoscopy was greatly impacted by the COVID-19 pandemic, which caused a slowdown in adoption and growth. In order to prioritize COVID-19-related healthcare needs and lower the risk of transmission in hospitals, elective surgeries, including those involving UBE, were delayed or cancelled during the early stages of the pandemic. Additionally, the availability of UBE equipment and training was hindered by the disruption of global supply chains and the redirection of healthcare resources towards pandemic management. UBE's potential for minimally invasive surgery, however, attracted renewed attention as healthcare systems adjusted and elective surgeries resumed, especially in markets seeking to shorten recovery times following surgery and enhance patient outcomes.

The Reusable segment is expected to be the largest during the forecast period

The unilateral bilateral endoscopy market is anticipated to be dominated by the reusable segment. Due in large part to their high recoverability rates through efficient sterilization and disinfection procedures, healthcare providers have adopted reusable products widely, which has led to their dominance. The classification of reusable instruments according to the risks of infection enables customized disinfection techniques that improve efficacy and safety. Furthermore, the market is expected to continue to be led by the reusable segment as minimally invasive surgeries gain popularity, but the single-use segment is expected to grow quickly because of growing concerns about infection control and the lower maintenance needs of single-use products.

The Ambulatory Surgery Centers segment is expected to have the highest CAGR during the forecast period

In the unilateral biportal endoscopy market, the ambulatory surgery centers (ASCs) segment is anticipated to grow at the highest CAGR. The rise in professionally owned and operated ASCs, which meet the growing demand for minimally invasive surgical procedures, is the main driver of this expansion. ASCs have a number of benefits that are appealing to patients and healthcare professionals alike, such as cost savings and the ease of same-day surgeries. Moreover, favourable reimbursement practices and a growing desire for procedures that shorten hospital stays are additional factors supporting the move towards outpatient care.

Region with largest share:

The market for unilateral biportal endoscopy is expected to be dominated by the North American region. The high incidence of non-communicable diseases, the sophisticated healthcare system, and the growing geriatric population that demands minimally invasive surgical procedures are all major contributors to this dominance. Due to its advantageous reimbursement policies and growing preference for cutting-edge surgical techniques, the United States in particular is a major player in this market. Additionally, North America is a key hub for unilateral biportal endoscopy innovations and applications due to the presence of major market players and ongoing technological advancements, which also greatly contribute to the region's growth.

Region with highest CAGR:

The unilateral biportal endoscopy market is anticipated to grow at the highest CAGR in the Asia-Pacific region. Rapid improvements in healthcare infrastructure, rising market player investments, and a laxer regulatory framework that promotes innovation and the uptake of new technologies are some of the factors driving this growth. Because of their growing medical expertise and rising demand for minimally invasive surgical procedures, nations like China and India are driving this momentum. Furthermore, the market is driven by the increasing incidence of spinal disorders, especially among the elderly population in this area, as medical professionals look for effective and efficient treatment alternatives.

Key players in the market

Some of the key players in Unilateral Biportal Endoscopy market include Stryker Corporation, Karl Storz, Conmed Corporation, Kinetix Lifesciences, Richard Wolf, Jiangsu Bonss Medical Technology Co. Ltd., Smith & Nephew, Maxer Endoscopy GmbH, Endovision Co. Ltd. and Joimax GmbH.

Key Developments:

In August 2024, Stryker announced a definitive agreement to acquire care.ai, a privately held company specializing in delivering AI-assisted virtual care workflows, smart room technology and ambient intelligence solutions. The acquisition will strengthen Stryker's growing healthcare IT offering and wirelessly connected medical device portfolio.

In June 2024, Karl Storz Endoscopy-America, a subsidiary of medical technology company Karl Storz Se & Co, has agreed to acquire Asensus Surgical. Under the agreement, KARL STORZ will acquire all outstanding shares of Asensus for $0.35 per share in cash.

In February 2024, Smith+Nephew, the global medical technology company, announces an agreement with NAVBIT to exclusively distribute the NAVBIT SPRINT(TM) in Australia. A single-use, sterile navigation system with everything provided in a small carton, NAVBIT SPRINT(TM) is designed to suit busy surgeons - and its convenient product format makes it extremely practical and cost efficient for hospitals and day surgery environments.

Products Covered:

• Reusable
• Single-use

Applications Covered:

• Decompression
• Deherniation
• Spinal Stabilization
• Other Applications

End Users Covered:

• Hospitals
• Ambulatory Surgery Centers
• Specialty Clinics
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 Application Analysis
• 3.8 End User Analysis
• 3.9 Emerging Markets
• 3.10 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Unilateral Biportal Endoscopy Market, By Product

• 5.1 Introduction
• 5.2 Reusable
• 5.3 Single-use

6 Global Unilateral Biportal Endoscopy Market, By Application

• 6.1 Introduction
• 6.2 Decompression
  • 6.2.1 Lumbar Central Canal Stenosis
  • 6.2.2 Degenerative Lumbar Canal Stenosis
  • 6.2.3 Lumbar Spinal Stenosis
• 6.3 Deherniation
• 6.4 Spinal Stabilization
• 6.5 Other Applications

7 Global Unilateral Biportal Endoscopy Market, By End User

• 7.1 Introduction
• 7.2 Hospitals
• 7.3 Ambulatory Surgery Centers
• 7.4 Specialty Clinics
• 7.5 Other End Users

8 Global Unilateral Biportal Endoscopy Market, By Geography

• 8.1 Introduction
• 8.2 North America
  • 8.2.1 US
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 Italy
  • 8.3.4 France
  • 8.3.5 Spain
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 Japan
  • 8.4.2 China
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 New Zealand
  • 8.4.6 South Korea
  • 8.4.7 Rest of Asia Pacific
• 8.5 South America
  • 8.5.1 Argentina
  • 8.5.2 Brazil
  • 8.5.3 Chile
  • 8.5.4 Rest of South America
• 8.6 Middle East & Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 UAE
  • 8.6.3 Qatar
  • 8.6.4 South Africa
  • 8.6.5 Rest of Middle East & Africa

9 Key Developments

• 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 9.2 Acquisitions & Mergers
• 9.3 New Product Launch
• 9.4 Expansions
• 9.5 Other Key Strategies

10 Company Profiling

• 10.1 Stryker Corporation
• 10.2 Karl Storz
• 10.3 Conmed Corporation
• 10.4 Kinetix Lifesciences
• 10.5 Richard Wolf
• 10.6 Jiangsu Bonss Medical Technology Co. Ltd.
• 10.7 Smith & Nephew
• 10.8 Maxer Endoscopy GmbH
• 10.9 Endovision Co. Ltd.
• 10.10 Joimax GmbH